We provide you with 20 years of free, institutional-grade data for OCX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of OCX. Explore the full financial landscape of OCX stock.
| Reported Date | CIK | Ticker | Type |
|---|
OncoCyte Corporation(NASDAQ:OCX) 
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early stage adenocarcinoma of the lung; and ...
Website: http://www.oncocyte.com
Founded: 2009
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about OCX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.